Max India [Merged] Peer Comparison

NSE: MAXINDIA | BSE: 539981

₹76.00

₹47.96 (171.08%)

As on 28-Aug-2020IST

Market cap

₹1,846 Cr

Revenue (TTM)

₹150 Cr

P/E Ratio

P/B Ratio

1.9

Div. Yield

0 %

Edit

	Max India [Merged]	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Market cap (₹ Cr)	1,846	231	94	38	30
Revenue (₹ Cr)	150	57	26	17	24
Net Profit (₹ Cr)	212.18	0.15	-0.45	1.93	-3.62
Net Margin (%)	-74.08	0.26	-1.72	10.69	-15.36
RoE (%)	--	0.26	-3.41	5.30	--
Price to Earnings	5.97	1,536.85	--	19.86	--
Price-To-Book	1.88	3.79	7.72	1.13	-11.34

Income Statement (₹ Cr)

	Max India [Merged]	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Operating Income	150.01	38.43	7.64	17.67	14.67
Other Income	1.60	0.68	0.25	0.14	0.24
Total Income	968.68	39.10	7.89	17.81	14.91
Interest Expense	22.93	0.21	0.96	0.18	0.53
PBT & Exceptional Items	-153.33	0.63	-5.18	1.73	-0.60
Operating Expenses	182.01	35.20	10.88	15.33	14.22
Exceptional Income/Expenses	-50.00	0.00	--	--	-0.40
Profit before Tax	-109.86	0.63	-5.18	1.73	-0.60
Taxes	2.45	-0.08	0.00	0.60	0.07
Profit after Tax	-112.31	0.71	-5.18	1.12	-0.67
Minority Interest	59.79	--	--	--	--
Share of Associate	37.50	--	--	--	--
Consolidated Profit	309.47	0.71	-5.18	0.54	-0.67

	Max India [Merged]	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Shareholder's Funds	1,054.33	50.12	5.19	10.97	6.41
Minority Interest	59.79	--	--	--	--
Non-Current Liabilities	176.13	-0.22	5.40	-1.83	1.86
Current Liabilities	1,057.55	5.62	4.21	2.34	6.52
Total Liabilities	2,335.05	56.52	14.80	13.32	14.84

	Max India [Merged]	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Non-Current Assets	932.88	48.93	12.50	8.68	9.03
Current Assets	1,459.05	6.59	2.30	2.81	5.76
Total Assets	2,335.05	56.52	14.80	13.32	14.84
Contingent Liabilities	6.33	0.29	--	0.09	0.03

	Max India [Merged]	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Cash From Operating Activities	-2.54	4.20	-3.39	3.82	0.67
Cash Flow from Investing Activities	14.25	-4.01	-1.97	-1.09	-0.47
Cash from Financing Activities	-15.62	-1.41	3.35	-1.75	0.33
Net Cash Inflow / Outflow	-3.90	-1.22	-2.00	0.99	0.53

	Max India [Merged]	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
ROCE (%)	-6.98	1.66	-34.50	14.94	-0.61
ROE (%)	-10.95	1.41	-187.57	9.86	-9.92
ROA (%)	-9.33	1.25	-37.93	9.59	-4.68
EBIT Margin (%)	-25.68	10.15	-39.20	14.05	4.69
Net Margin (%)	-74.08	1.81	-65.69	6.32	-4.49
Cash Profit Margin (%)	0.00	9.80	-51.78	9.60	0.60

	Max India [Merged]	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Revenue Growth (%)	2.05	1.06	75.25	1.75	9.98
EBIT Growth (%)	-335.79	-25.16	18.04	5.51	-45.31
Net Profit Growth (%)	-374.22	-59.47	7.15	19.12	-313.48
EPS Growth (%)	-103.36	-59.47	41.15	19.12	-313.49
Book Value Growth (%)	-3.66	-1.02	1,450.51	-7.39	-9.46

	Max India [Merged]	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Price / Earnings	0.00	65.06	0.00	19.11	0.00
Price / Book Value	1.53	0.92	4.32	1.96	0.00
Dividend Yield (%)	0.00	0.00	0.00	5.46	--
EV/EBITDA	-25.11	11.20	-9.99	8.61	12.34
Market Cap (₹ Cr)	1,786.29	46.06	22.41	21.49	0.00

	Max India [Merged]	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Debt to Equity	0.15	0.00	1.46	0.11	0.83
Short term debt to equity ratio	0.00	0.00	0.38	0.11	0.51
Current Ratio	1.38	1.17	0.55	1.20	0.88
Quick Ratio	1.15	0.79	0.48	1.38	0.68
Interest Coverage	-3.79	3.93	-4.39	10.62	-0.13

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.